Claritev Corporation filings document a healthcare technology, data and insights issuer with Class A common stock listed on the NYSE under CTEV. Its Form 8-K reports furnish operating results, financial-condition updates, investor presentations and Regulation FD materials tied to its analytics, AI and claims-based healthcare cost-management platform.
Proxy and annual-meeting filings cover board elections, auditor ratification, executive compensation, stockholder votes and amendments to the Claritev Corporation 2020 Omnibus Incentive Plan. Other material-event reports address share-repurchase authorization, capital-structure matters and governance transitions.
Claritev Corp EVP and COO Jerome Hogge reported equity award and related tax dispositions. On March 1, 2026, he received 66,322 shares of Class A common stock as a grant. The filing also shows share dispositions tied to tax withholding and the cash settlement of previously granted cash-settled RSUs.
Claritev Corp senior vice president and chief strategy officer William B. Mintz reported equity compensation activity tied to restricted stock units. On March 1, 2026, he disposed of 6,431 cash-settled RSUs back to the company upon vesting of half of a 2025 cRSU grant, leaving 6,432 cash-settled RSUs outstanding. On the same date, 1,137 Class A common shares at $13.47 per share were withheld to cover taxes on vesting of earlier RSUs. He also received a new grant of 19,060 restricted stock units, scheduled to vest in four equal annual installments of 25% each on March 1, 2027, 2028, 2029, and 2030. Following these transactions, Mintz directly held 83,248 shares of Class A common stock.
Claritev Corp reported that SVP and Chief Accounting Officer Albinson Brock acquired an equity award tied to 23,243 shares of Class A common stock as a grant of restricted stock units. These RSUs vest 25% each on March 1 of 2027, 2028, 2029 and 2030. Following this grant, Brock beneficially owns 27,237 shares directly.
Claritev Corp SVP and Chief Growth Officer Tiffani Misencik reported a mix of equity award activity and related share dispositions. She received a grant of 26,342 restricted stock units, which will vest 25% each year on March 1 of 2027, 2028, 2029, and 2030.
On the same date, 10,123 cash-settled restricted stock units granted in 2025 were settled in cash following the vesting of 50% of that award. In addition, 1,660 shares of Class A common stock at $13.47 per share were withheld to cover taxes on vesting, leaving her with 132,573 Class A shares directly owned.
Claritev Corp executive Carol Nutter, SVP and Chief People Officer, reported multiple equity transactions. She received a grant of 18,130 shares of Class A common stock as restricted stock units, which will vest 25% each on March 1 of 2027, 2028, 2029 and 2030.
On the same date, Nutter disposed of 1,229, 498 and 1,085 Class A shares at $13.47 per share to cover taxes on vesting RSUs originally granted in 2023, 2024 and 2025. She also disposed of 6,127 cash-settled restricted stock units through a cash settlement tied to 50% vesting of a prior cRSU grant. After these transactions, she directly owns 46,066 Class A shares.
Claritev Corp director and CEO Dalton Travis reported a mix of equity award activity and related share disposals on March 1, 2026. He received a grant of 278,925 shares of Class A common stock as a restricted stock unit award, recorded as a grant or other acquisition. To cover tax obligations from vesting of earlier restricted stock units granted on March 1, 2024 and March 1, 2025, 13,806 and 9,824 Class A shares, respectively, were disposed of through tax-withholding transactions at a price of $13.47 per share. In addition, 190,566 cash settled restricted stock units granted on March 1, 2025 were settled in cash upon vesting of 50% of those units, reducing his position in that derivative security. After these transactions, he directly held 498,353 Class A shares and 190,567 cash settled restricted stock units, and there were 24,952 Class A shares held indirectly through his spouse’s individual retirement account.
Claritev Corp executive vice president and chief digital officer Kim Michael reported an open-market purchase of 30,000 shares of Class A common stock on February 27, 2026 at a weighted average price of $14.2985 per share. Following this transaction, Michael directly owns 137,973 shares.
Claritev Corp director and Pres., CEO & Executive Chair Dalton Travis reported an open-market purchase of 15,380 shares of Class A common stock on February 27, 2026. The shares were bought indirectly through his spouse's individual retirement account at a weighted average price of $12.9992 per share. After these transactions, he reported 24,952 shares held indirectly through the spouse’s IRA and 243,058 shares held directly.
Claritev Corp senior vice president and general counsel Tara O'Neil reported an open-market purchase of 750 shares of Class A common stock at a price of $12.99 per share. Following this transaction, her directly held stake increased to 27,199 shares.
Claritev Corporation describes itself as a technology, data and insights company focused on reducing cost, risk and complexity in the U.S. healthcare system. The company serves more than 750 payer clients and estimates its solutions touch over 60 million consumers through 100,000+ plan sponsors.
Claritev reports identifying $25.0 billion in potential savings on $179.8 billion in claim charges in 2025, leveraging a platform that processes about 30 million claims per month and a proprietary network of over 1.4 million contracted providers. It estimates total addressable markets of roughly $10.0 billion for out-of-network cost management, $3.0 billion for in‑network payment and revenue integrity, and $17.0 billion for newer analytics and transparency offerings.
The report outlines the Vision 2030 strategy and notes 2025 was branded “THE TURN,” marking a return to year‑over‑year revenue growth, with 2026 branded “THE WAY UP.” Key risks include dependence on a few large clients, high leverage, intense competition, extensive healthcare regulation and cybersecurity and data‑privacy exposure. As of June 30 2025, non‑affiliate market value was about $505.8 million, and as of February 23 2026, 16,552,723 Class A shares were outstanding.